Buscar
Mostrando ítems 1-10 de 29
Pesquisa de métodos cromatográficos para quantificação e caracterização do certolizumabe pegol
(Universidade Federal de Santa MariaBrasilAnálises Clínicas e ToxicológicasUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasCentro de Ciências da Saúde, 2022-05-24)
Certolizumab pegol (CZP) is a fragment of a recombinant humanized monoclonal
antibody (mAb) produced in E. coli, conjugated with polyethylene glycol (PEG) that
acts by inhibiting the activity of Tumor Necrosis Factor ...
Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: A systematic literature review based on 222 cases
(2013-01-01)
Background: Paradoxical cases of psoriatic lesions induced or exacerbated by anti-tumor necrosis factor (TNF)-α therapy have been reported more frequently in recent years, but data related to inflammatory bowel disease ...
Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: A systematic literature review based on 222 cases
(2013-01-01)
Background: Paradoxical cases of psoriatic lesions induced or exacerbated by anti-tumor necrosis factor (TNF)-α therapy have been reported more frequently in recent years, but data related to inflammatory bowel disease ...
Eventos adversos con Certolizumab reportadops en Bogotá D. C. 2012-2017
(Facultad de CienciasQuímica Farmacéutica, 2018)
Introducción: .El Certolizumab Pegol está compuesto de un anticuerpo monoclonal humanizado recombinante contra el factor de necrosis tumoral α (TNFα) expresado en Escherichia coli y conjugado con polietilenglicol (PEG) 1. ...
Experiencia terapéutica a certolizumab pegol en pacientes con artritis reumatoide del hospital ISSSTEP: estudio piloto de la correlación del índice de masa corporal y respuesta clínica
(Benemérita Universidad Autónoma de Puebla, 2021-02)
"La artritis reumatoide es una de las enfermedades reumáticas más prevalentes en nuestra población y de las que mayor discapacidad física ocasionan en los pacientes que la padecen. Actualmente existen diversas opciones ...
Inflammatory Bowel Disease: An Overview Of Immune Mechanisms And Biological Treatments
(HINDAWI PUBLISHING CORPORATIONNEW YORK, 2015)